Titan Biotech Ltd

BSE: 524717

7

total announcements

524717.BO · 15 min delayed

BSEInsider Trading / SASTMgmt Change1d ago

Titan Biotech Ltd

Closure of Trading Window

Titan Biotech Ltd has announced the closure of its trading window for all Designated Persons, their Immediate Relatives and Connected Persons until 48 hours after the conclusion of the Board Meeting scheduled to be held on September 03, 2026, to consider the proposal for issue of Bonus Shares.

Read more →📎 1 attachment
BSEBoard MeetingResults5 Aug 2026

Titan Biotech Ltd

Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the standalone and consolidated ....

Titan Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026.

Read more →📎 1 attachment
BSEInsider Trading / SAST23 Jun 2026

Titan Biotech Ltd

Closure of trading window

Titan Biotech Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure, effective from July 1, 2026, is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed until 48 hours after the company declares its unaudited financial results for the quarter ended June 30, 2026. The specific date for the board meeting to approve these results will be communicated later.

Read more →📎 1 attachment